02 August 2010

Stem Cell Trial Approved by FDA

The New York Times reports:
Stem Cell Trial Wins Approval of FDA
by Andrew Pollack

The world’s first authorized test in people of a therapy derived from human embryonic stem cells has been cleared by the Food and Drug Administration.

The clinical trial could offer the first glimpse of the safety and possible effectiveness of a technology that has been hailed for its vast medical promise but also embroiled in political and ethical controversy.

The trial will test cells developed by the Geron Corporation and the University of California, Irvine in patients with new spinal cord injuries.


The F.D.A. had initially cleared the clinical trial in January 2009. But before any patients could be treated, the agency suspended the trial after cysts were discovered in some rats injected with the cells. Geron had to do another rat study and develop better ways to check cell purity.

Embryonic stem cells can turn into any type of cell in the body. Scientists envision one day making replacements for injured or diseased tissues to treat a wide variety of illnesses.

“I think it’s a very important milestone for the whole industry,” Alan Trounson, the president of California’s stem cell agency, said Friday, adding that the hold on the trial had been a cloud over the field. “It’s very important that they get on and treat the patients and demonstrate the safety” of the therapy.
But the cells have been controversial because their creation has involved the destruction of human embryos, though some researchers claim they can now avoid that.
Well, it is already legal to murder "unwanted" babies in the name of women's rights. It only makes sense, then, that the next step would be to destroy life from the very beginning in the name of medical advancement. What is both sad and maddening, however, is that research of the use of adult stem cells is far more advanced than that of embryonic stem cells. The best part about adult stem cell therapy? Nobody has to die.

No comments:

Post a Comment

Please keep it pithy (in other words, if your comment is long enough to be its own blog post, don't bother), pertinent (please don't go off-topic), and respectful (to the author, to the other readers, and to the subject of the post). If you can't do that, your comment will not be posted.

If you haven't already, please read the Comment Policy in its entirety.